DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.38+0.05 (+0.60%)
Close on Nov 17, 2026Market cap $451.90MP/E –Yield –
DiaMedica Therapeutics net income
Net income is the profit left for shareholders after every expense, interest and tax.
DiaMedica Therapeutics's net income for the twelve months ending Jun 30, 2026 was -$37.54M. For fiscal 2025 it was -$32.77M. The highest annual figure on record is -$4.26M in fiscal 2017.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$32.77M | – |
| FY2024 | Dec 31, 2024 | -$24.44M | – |
| FY2023 | Dec 31, 2023 | -$19.38M | – |
| FY2022 | Dec 31, 2022 | -$13.68M | – |
| FY2021 | Dec 31, 2021 | -$13.59M | – |
| FY2020 | Dec 31, 2020 | -$12.29M | – |
| FY2019 | Dec 31, 2019 | -$10.65M | – |
| FY2018 | Dec 31, 2018 | -$5.73M | – |
| FY2017 | Dec 31, 2017 | -$4.26M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.14M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.04M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.74M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.62M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.70M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.71M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.90M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.27M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.12M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.15M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.16M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.47M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.48M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.27M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.75M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.06M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.36M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.51M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.25M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.45M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.27M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.62M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.20M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.19M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.47M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.43M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.48M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.45M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.47M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.25M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.96M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.39M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.74M | – |
| Q1 FY2018 | Mar 31, 2018 | -$650.00K | – |
See a number that looks wrong?